Serum Institute of India is the vaccine producer that will invest 50 million pounds ($68.24 million) in Oxford Biomedica, one of the COVID-19 vaccine manufacturers for drug major AstraZeneca, the British cell therapy firm said.

• Vedanta Outlook for the Week (April 22, 2024 – April 26, 2024)
• Tata Steel Outlook for the Week (April 22, 2024 – April 26, 2024)
• PFC Outlook for the Week (April 22, 2024 – April 26, 2024)
• Piramal Enterprises Outlook for the Week (April 22, 2024 – April 26, 2024)
• MANAPPURAM Outlook for the Week (April 22, 2024 – April 26, 2024)

The proceeds of the transaction will be used to fund the development of the fallow area at Oxbox, the group’s 84,000 sq. ft manufacturing facility based in Oxford, UK, into a flexible advanced manufacturing space and the validation of several independent cGMP suites, expected to come online in mid-2023.